PREMIER INC-CLASS A (PINC) Stock News
NASDAQ:PINC - Nasdaq - US74051N1028 - Common Stock - Currency: USD
PINC Latest News, Press Relases and Analysis
Should Value Investors Buy Premier (PINC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Premier Announces the Nation’s 15 Top Health Systems®
Premier, Inc. named as data source in HealthVerity Marketplace™ to expand real-world data access for life sciences research
/PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced the addition of Premier, Inc....
Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 13, 2025
Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses
SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset the sales decline.
Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?
STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter.
Premier (PINC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Premier (PINC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Premier, Inc. (PINC) Q3 Earnings and Revenues Beat Estimates
Premier (PINC) delivered earnings and revenue surprises of 41.94% and 9.42%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PACS
MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings?
McKesson's fourth-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
Premier, Inc. Reports Fiscal-Year 2025 Third-Quarter Financial Results
Icon PLC (ICLR) Beats Q1 Earnings Estimates
Icon PLC (ICLR) delivered earnings and revenue surprises of 3.57% and 0.58%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ICLR
Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for
Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: CRL
Premier, Inc. (PINC) Expected to Beat Earnings Estimates: Should You Buy?
Premier (PINC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: CVS
Jim Cramer on CVS Health Corporation (CVS): “Put up some really good numbers” – New Leadership and Cleaned-Up Stores
We recently published a list of Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer discussed. On Friday, Mad Money host Jim Cramer took a close look at what he […]
Premier, Inc. Declares Quarterly Cash Dividend
Are Investors Undervaluing Premier (PINC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
